Opthea to Present at H.C. Wainwright & Cantor Conferences
Ticker: OPTEY · Form: 6-K · Filed: Sep 3, 2024 · CIK: 1815620
Sentiment: neutral
Topics: conference-participation, investor-relations
TL;DR
Opthea is hitting up two big investor conferences next month, look for updates.
AI Summary
Opthea Limited announced its participation in two upcoming investor conferences: the H.C. Wainwright 26th Annual Global Investment Conference and the Cantor 2024 Global Healthcare Conference. These events will provide opportunities for Opthea to present its business and engage with the investment community.
Why It Matters
Participation in these conferences allows Opthea to increase visibility with potential investors and partners, which could be crucial for future funding and strategic development.
Risk Assessment
Risk Level: low — This filing is an announcement of participation in conferences, which is routine and does not involve significant new financial or operational information.
Key Players & Entities
- Opthea Limited (company) — Registrant
- H.C. Wainwright (company) — Conference Organizer
- Cantor (company) — Conference Organizer
FAQ
Which specific conferences will Opthea Limited be participating in?
Opthea Limited will be participating in the H.C. Wainwright 26th Annual Global Investment Conference and the Cantor 2024 Global Healthcare Conference.
When is the filing period for this Form 6-K?
The filing is for the month of September 2024.
What is Opthea Limited's principal executive office address?
Opthea Limited's principal executive office is located at Level 4, 650 Chapel Street, South Yarra, Victoria, 3141, Australia.
Does Opthea Limited file under Form 20-F or Form 40-F?
Opthea Limited files under Form 20-F.
What is the SIC code for Opthea Limited?
The Standard Industrial Classification (SIC) code for Opthea Limited is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Stats: 157 words · 1 min read · ~1 pages · Grade level 12 · Accepted 2024-09-03 06:06:06
Filing Documents
- opt_announces_hc_septemb.htm (6-K) — 23KB
- opt-ex99_1.htm (EX-99.1) — 20KB
- img260626642_0.jpg (GRAPHIC) — 61KB
- img260626642_1.jpg (GRAPHIC) — 61KB
- 0000950170-24-102542.txt ( ) — 211KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. OPTHEA LIMITED (Registrant) By: /s/ Frederic Guerard Name: Frederic Guerard Title: Chief Executive Officer Date: 09/03/2024